Primary Axillary Hyperhydrosis. Primary focal hyperhidrosis, axilla
Conditions
Interventions
Intervention 1: Intervention group:All 15 participants in this study will be injected with 165 IU botulinum toxin type A Masport (each vial contains 500 IU of botulinum toxin type A that will be dilut
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Adults aged between 18 to 65 years who have a sweating rate of 50 mg per minute or higher.
Exclusion criteria
Exclusion criteria: secondary Hyperhidrosis due to systemic problems. Pregnancy Lactation people who have taken Aminoglycosides in the last three weeks. people who have had botulinum toxin injection in the past year. people with Neuromuscellar diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The score of sweating rate in the questionnaire of "Hyperhidrosis disease severity scale" by patients. Timepoint: scoring of the amount of sweating will be done on day 0 (before the stat of the study), 14, 90 and 180 days after botulinum toxin injection. Method of measurement: The questionnaire "Hyperhidrosis disease severity scale".;Sweating rate based on Gravimetry test. Timepoint: measurement of the sweating will be done on day 0 (before the stat of the study), 14, 90 and 180 days after botulinum toxin injection. Method of measurement: Using a digital scale.;Occurrence of the side effects, The time of onset and duration of the complication. Timepoint: Patients will be able to report occurrence of the side effects throughout the study, but they will be asked specifically on 14th, 90th and 180th after Botulinum Toxin injection. Method of measurement: Statements of patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactkamand Hedayat
Pasture Institute of Iran
Outcome results
None listed